1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
682243E52FFF55C2685256EF900706A02
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/may-2002-gbc-presentation-the-johnson-johnson-name-how-to-establish-a-trustmark-johnson-johnson?opendocument
18
19opendocument
20107.23.176.162
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services R and AS Conferences 2002 May 2002: Seeing Your Brands Through Your Customers' Eyes

May 2002 GBC Presentation: The Johnson & Johnson Name: How to Establish a Trustmark (Johnson & Johnson)

ID: GBC-P052002JNT


Published: Pre-2013


Delivery Format: PowerPoint


 

close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.


Buy Now

Direct access to this research is not included with your membership level.

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • PRESENTER INFO
For 116 years, Johnson & Johnson (J&J) has built its name and reputation as a manufacturer of the highest quality products and services. The red Johnson & Johnson signature - the company’s logo - is known worldwide as an emblem of trust and highest ethical standards. Along with Johnson & Johnson’s Credo, this "trustmark" guides the behavior of the company’s employees. Johnson & Johnson is entrusted with a valuable brand asset - generations of emotional connection and confidence - and commits to protecting this asset through a great respect for the unique regard in which J&J is held. Nancy Lewin, Johnson & Johnson’s Director of Corporate Equity and New Ventures, will share the company’s techniques and lessons learned in creating and maintaining a "trustmark."

Industries Profiled:
Pharmaceutical; Health Care


Companies Profiled:
Johnson & Johnson

Nancy Lewin
Director of Corporate Equity and New Ventures

Johnson & Johnson